Monocentric Evaluation of incidence of psychosocial comorbidities in patients with chronic urticaria

Monocentric Evaluation of incidence of psychosocial comorbidities in patients with chronic urticaria - UpsysoKo

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00022912

Enrollment

100

Registered

2020-08-19

Start date

2020-08-25

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

L50.9

Interventions

Group 1: patients with chronic urticaria evaluation of incidence of psychosocial comorbidities (such as anxiety, depression, social network) and the influence of duration, severity, therapy options on

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: physichian diagnosed chronic urticaria informed consent

Exclusion criteria

Exclusion criteria: age blow 18 no informed consent no chronic urticaria

Design outcomes

Primary

Measure	Time frame
Allgemeine Depressionsskala (ADS), Generalized Anxiety Disorder (GAD-7, Lubben social Network Scale (LSNS), Health Survey (SF-8), Dermatological Quality of Life Index, HADS-D - Hospital Anxiety and Depression Scale - German version at the time of the survey	—

Secondary

Measure	Time frame
self-medication with drugs, naturopathic treatment at the time of the survey	—

Countries

Germany

Contacts

Public ContactPaula Kage

Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie Universitätsklinikum Leipzig

paula.kage@uniklinik-leipzig.de03419718364

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026